MedTrace Logo

Study in Patients' With Persistent Asthma and Chronic Obstructive Pulmonary Disease

NCT02419872 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1743

Last updated 2017-11-07

No results posted yet for this study

Summary

The study is to evaluate the percentage of patients with asthma or COPD achieving disease control

Conditions

Interventions

DRUG

Marketed antagonists

Medication for each patient is determined by the physician based on the patient's individual clinical profile and in accordance with the approved indication and label of the prescribed drug

Sponsors & Collaborators

  • Teva Pharmaceuticals Europe

    lead INDUSTRY

Principal Investigators

  • Teva Medical Expert, MD · Teva Pharmaceuticals USA

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2017-04-07
Completion
2017-04-07

Countries

  • Croatia
  • Denmark
  • Ireland
  • Italy
  • Netherlands
  • Norway
  • Portugal
  • Spain
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02419872 on ClinicalTrials.gov